Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
- 18 March 2006
- journal article
- review article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 56 (1) , 95-100
Abstract
Tumor growth and dissemination depend partly on the reactivity of natural killer (NK) cells and T cells expressing NK-associated receptors. Their effector functions are regulated by an array of activating and inhibitory cell surface receptors with MHC class I ligand specificity, such as the killer immunoglobulin-like receptors (KIRs). Given the extensive genomic diversity of KIRs and their HLA ligands, it is reasonable to speculate that HLA, KIR gene variations and specific KIR-ligand combinations will have an impact on disease susceptibility and/or progression. Here, we discuss how KIR genotypes and KIR/HLA immunogenetic profiles may be involved in tumorigenesis, especially in malignant melanoma (MM). A hypothetical model of the impact of KIR/ligand combinations on immune responses in MM is proposed.Keywords
This publication has 34 references indexed in Scilit:
- A population‐based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasiaTissue Antigens, 2005
- MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4The Journal of Immunology, 2004
- The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escapeCancer Immunology, Immunotherapy, 2004
- Development of a PCR‐SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoiresTissue Antigens, 2000
- HLA‐DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian populationTissue Antigens, 1998
- Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA‐Cw4 moleculesEuropean Journal of Immunology, 1997
- The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.Journal of Experimental Medicine, 1996
- Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.Journal of Experimental Medicine, 1995
- NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.Journal of Experimental Medicine, 1994
- IMMUNOLOGICAL ASPECTS OF MALIGNANT DISEASEThe Lancet, 1967